These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22531025)

  • 21. Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor.
    Takeda T; Sakurai Y; Tatsumi K; Kato J; Kasuda S; Yoshioka A; Shima M
    Thromb Haemost; 2009 Feb; 101(2):408-10. PubMed ID: 19190830
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of rituximab in two children with allo-antibodies towards factor VIII.
    Curry N; Stanworth S; Keeling D
    Br J Haematol; 2006 Apr; 133(2):214-6. PubMed ID: 16611318
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of patients with acquired inhibitors.
    Sallah S; Aledort L
    J Thromb Haemost; 2005 Mar; 3(3):595-7. PubMed ID: 15748261
    [No Abstract]   [Full Text] [Related]  

  • 24. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.
    Berntorp E; Figueiredo S; Futema L; Pock K; Knaub S; Walter O; Trawnicek L; Römisch J
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):577-83. PubMed ID: 20644466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases.
    Mauro E; Garlatti Costa E; Zanier A; Maset M; Ermacora A; Ghersetti M; Casarin P
    Reumatismo; 2019 Apr; 71(1):37-41. PubMed ID: 30932442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term outcome of patients with acquired haemophilia--a monocentre interim analysis of 82 patients.
    Zeitler H; Goldmann G; Marquardt N; Ulrich-Merzenich G
    Atheroscler Suppl; 2013 Jan; 14(1):223-8. PubMed ID: 23357169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pemphigoid and acquired hemophilia].
    Lightburn E; Morand JJ; Graffin B; Molinier S; Raphenon G; Poullin P; Harlé JR; Chouc C
    Ann Dermatol Venereol; 2001 Nov; 128(11):1229-31. PubMed ID: 11908168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired haemophilia in the elderly.
    Geurs F; Baele G; Afschrift M
    Acta Clin Belg; 1995; 50(4):238-41. PubMed ID: 7483976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.
    Bidlingmaier C; Kurnik K; Escuriola-Ettingshausen C; Jager R; Klamroth R; Male C; Marosi A; Nemes L; von Stackelberg A; Kreuz W
    Haemophilia; 2011 Sep; 17(5):e837-40. PubMed ID: 21649797
    [No Abstract]   [Full Text] [Related]  

  • 31. A study of 65 patients with acquired hemophilia A in Taiwan.
    Huang SY; Tsay W; Lin SY; Hsu SC; Hung MH; Shen MC
    J Formos Med Assoc; 2015 Apr; 114(4):321-7. PubMed ID: 25839765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and course of inhibitors among patients with classic hemophilia.
    Kasper CK
    Thromb Diath Haemorrh; 1973 Nov; 30(2):263-71. PubMed ID: 4773365
    [No Abstract]   [Full Text] [Related]  

  • 33. Solid tumors and factor VIII antibodies.
    Hauser I; Lechner K
    Thromb Haemost; 1999 Sep; 82(3):1005-7. PubMed ID: 10494753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durable responses to rituximab in acquired factor VIII deficiency.
    Singh AG; Hamarneh IS; Karwal MW; Lentz SR
    Thromb Haemost; 2011 Jul; 106(1):172-4. PubMed ID: 21544323
    [No Abstract]   [Full Text] [Related]  

  • 35. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.
    Smith MP; Spence KJ; Waters EL; Beresford-Webb R; Mitchell MJ; Cuttler J; Alhaq A; Brown SA; Savidge GF
    Thromb Haemost; 1999 Jan; 81(1):35-8. PubMed ID: 9974371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired haemophilia A in a woman with autoimmune hepatitis and systemic lupus erythematosus; review of literature.
    Rezaieyazdi Z; Sharifi-Doloui D; Hashemzadeh K; Shirdel A; Mansouritorghabeh H
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):71-4. PubMed ID: 22027758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.